These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6773242)

  • 21. The current status of blood fractionation in the United States.
    Sgouris JT
    Vox Sang; 1972; 23(1):45-55. PubMed ID: 5081014
    [No Abstract]   [Full Text] [Related]  

  • 22. [Problems in post-transfusion hepatitis].
    Fiedler H
    Munch Med Wochenschr; 1972 Mar; 114(12):549-52. PubMed ID: 5067649
    [No Abstract]   [Full Text] [Related]  

  • 23. [Conclusion to the paper: Risk of hepatitis caused by blood and blood products and possibilities of hepatitis prevention].
    Meyer zum Büschenfelde KH
    Internist (Berl); 1975 Sep; 16(9):445. PubMed ID: 1102482
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hepatitis hazards through blood and blood products and possibilities of hepatitis prevention].
    Meyer KH; Bolte JP
    Internist (Berl); 1974 Sep; 15(9):471-8. PubMed ID: 4607645
    [No Abstract]   [Full Text] [Related]  

  • 25. Letter: Rates of post-transfusion hepatitis.
    Allen JG
    N Engl J Med; 1975 May; 292(20):1078-9. PubMed ID: 1124092
    [No Abstract]   [Full Text] [Related]  

  • 26. Precipitation methods in plasma fractionation.
    Steinbuch M
    Vox Sang; 1972; 23(1):92-106. PubMed ID: 5081018
    [No Abstract]   [Full Text] [Related]  

  • 27. Prothrombin complex and fibrinogen.
    Wilson JG
    S Afr Med J; 1975 Jul; 49(31):1247-9. PubMed ID: 1154190
    [No Abstract]   [Full Text] [Related]  

  • 28. Reducing hepatitis transmission from 125I-fibrinogen.
    Jackson GL
    Pa Med; 1979 Apr; 82(4):24-7. PubMed ID: 440766
    [No Abstract]   [Full Text] [Related]  

  • 29. Individual nucleic amplification technology does not prevent all hepatitis B virus transmission by blood transfusion.
    Inaba S; Ito A; Miyata Y; Ishii H; Kajimoto S; Tanaka M; Maruta A; Saito S; Yugi H; Hino M; Tadokoro K
    Transfusion; 2006 Nov; 46(11):2028-9. PubMed ID: 17076860
    [No Abstract]   [Full Text] [Related]  

  • 30. Determination of alanine aminotransferase in blood donor screening--evidence of its usefulness in the prevention of post-transfusion hepatitis.
    Khouri ST; Lopes EP; Perez RM; Figueiredo VM; Lanzoni VP; Silva AE; Ferraz ML
    Clin Lab; 2004; 50(5-6):291-4. PubMed ID: 15209437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hepatitis following blood transfusions].
    Busch H
    Dtsch Med Wochenschr; 1971 Nov; 96(47):1851. PubMed ID: 5121116
    [No Abstract]   [Full Text] [Related]  

  • 32. [Transmission of hepatitis by transfusion].
    Fiser-Herman M; Polak A
    Lijec Vjesn; 1970; 92(5):545-53. PubMed ID: 5205536
    [No Abstract]   [Full Text] [Related]  

  • 33. AABB-CAP survey data on hepatitis--incidence, surveillance, and prevention.
    Polesky HF; Hanson M
    Am J Clin Pathol; 1980 Oct; 74(4 Suppl):565-8. PubMed ID: 7435449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Discussion comment on the paper by K.H. Meaer zum Büschenfelde and J.P.Bolte: Risk of hepatitis caused by blood and blood products and possibilities of hepatitis prevention, (this J. 15, 471-478(1974))].
    Internist (Berl); 1975 Sep; 16(9):444-5. PubMed ID: 1102481
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of gamma-globulin in prevention of fibrinogen-transmitted hepatitis.
    Ekblom L; Olsson P; Aberg T
    Acta Chir Scand; 1967; 133(5):351-4. PubMed ID: 4167870
    [No Abstract]   [Full Text] [Related]  

  • 36. [On our preventive measures for posttransfusion hepatitis].
    Inoguchi K; Ikejiri T; Kurashige M; Yamaguchi K
    Shujutsu; 1965 Sep; 19(9):725-32. PubMed ID: 5885750
    [No Abstract]   [Full Text] [Related]  

  • 37. Posttransfusion viral hepatitis (PTVH): myths and facts.
    Alsever JB; Van Schoonhoven PV
    Ariz Med; 1974 Apr; 31(4):263-7. PubMed ID: 4830446
    [No Abstract]   [Full Text] [Related]  

  • 38. A random controlled study of the prophylactic effect of lysozyme chloride on post-transfusion hepatitis.
    Sato M; Oe H; Nakano M; Kawasaki H; Hirayama C
    Hepatogastroenterology; 1981 Jun; 28(3):135-8. PubMed ID: 7019033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylaxis of posttransfusion hepatitis.
    Hässig A
    Minn Med; 1969 Jan; 52(1):59-61. PubMed ID: 5762361
    [No Abstract]   [Full Text] [Related]  

  • 40. [Transfusion hepatitis].
    Haussmann HG
    Landarzt; 1967 Jul; 43(19):899-905. PubMed ID: 5616133
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.